The risk could be fewer with bromocriptine. agonists utilized for hyperprolactinemia haven't shown a heightened chance of valvular heart disease, but the possibility need to be mentioned with people, and echocardiographic surveillance should be thought of, particularly when doses > three mg per week are applied. The chance could be significantly le